IP Library Assignment 019302/0403
Patent Assignment
Reel/Frame 019302/0403

Assignment of Assignor's Interest

Recorded: 2007-05-16 Pages: 5
Assignors
KWOK, DAVID W.K.
Executed: 2007-01-24
STOYNOV, NIKOLAY MINTCHEV
Executed: 2007-05-08
Assignee
PANION & BF BIOTECH, INC.
16/FL, NO. 3, YUANQU STREET, NANGANG DISTRICT, TAIPEI, TAIWAN
Covered Properties (2)
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 7,767,851 →
Application: 11/206,981 →
Publication: US 2006/0020026
Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Application: 60/709,511 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0338 →
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0598 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0708 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0830 →
Nunc Pro Tunc Assignment Jan 22, 2014
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 032022/0001 →
Security Interest Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Sixth Amended and Restated Intellectual Property Security Agreement Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Seventh Amended and Restated Intellectual Property Security Agreement Sep 12, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 057474/0770 →
Security Interest Dec 15, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058399/0055 →
Tenth Amended and Restated Intellectual Property Security Agreement Jun 16, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 060529/0168 →
Eleventh Amended and Restated Intellectual Property Security Agreement Aug 22, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 061297/0238 →
Twelfth Amended and Restated Intellectual Property Security Agreement Nov 29, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 062012/0561 →
Thirteenth Amended and Restated Intellectual Property Security Agreement Mar 29, 2023
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063189/0065 →
Fifteenth Amended and Restated Intellectual Property Security Agreement Jan 4, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066205/0143 →
Termination and Release of Security Interest in Patents Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Termination and Release of Security Interest in Patents Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →